SAN DIEGO, July 06, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced it will be participating in the 2nd Annual Cantor Fitzgerald Healthcare Conference on Tuesday, July 12, 2016. Jeffrey Stein, Ph.D., president and chief executive officer of Cidara, is scheduled to present at 9:30 a.m. EDT (6:30 a.m. PDT). The conference is being held in New York City. A live…
wpengineJuly 6, 2016